Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.

Int J Nanomedicine · 2008 · PMC2636580 · PMID 19337408

Europe PMC DOI

hedged sentence

0.5000

closest p · 10.0× alpha

0.5000

boldest claim

The sentences

a strong trendp > 0.5not close (p > 0.1)

Moreover, a strong trend in favor of DepoCyte ® in terms of time to neurological progression (78 versus 42 days; p > 0.5) and overall survival (99 versus 63 days; p > 0.5) was observed.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.